Pfizer: Protracted Selloff Makes This Best Time To Buy For A Decade
Pfizer's revenues were declining prior to the pandemic, but the success of its COVID vaccine and antiviral brought in unexpected additional revenues of >$55bn over 2 years. The company has been on ...
Pfizer maternal RSV vaccine recommended by CDC advisors
A Centers for Disease Control and Prevention advisory committee on Friday recommended pregnant people get Pfizer Inc.'s PFE, -0.56% maternal vaccine to protect babies from respiratory syncytial vir...
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
CDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer's shot to protect their infants from RSV.
US CDC panel weighs use of Pfizer's maternal RSV vaccine to protect infants
A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's respiratory syncytial virus (RSV) vaccine in pregnant women, likely pavin...
ARS Pharma shares bomb on surprise FDA rebuff
Shares of ARS Pharmaceuticals Inc plummeted 51% in premarket trading after the US Food and Drug Administration (FDA) unexpectedly declined to approve its needle-free nasal spray, Neffy, designed fo...
Pfizer's (PFE) Alopecia Areata Drug Litfulo Receives EU Nod
Pfizer (PFE) gets marketing authorization in the EU for Litfulo to treat adults and adolescent patients aged 12 years and older with severe alopecia areata.
Pfizer Stock: Bear vs. Bull
Pfizer is planning to acquire businesses and assets to power its growth. It'll be fighting against falling coronavirus medicine sales and also generic drugs.
Shares of COVID-19 Vaccine Makers Fall After Pfizer CFO Warns of Outlook 'Haircut'
Moderna (MRNA) was the worst-performing stock in the S&P 500 as shares dropped 9% after Pfizer CFO David Denton said the outlook for vaccine rates this year got a significant "haircut." Pfizer (PFE...
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, ...
Pfizer expects 24% uptake of COVID vaccines in US - CFO
Pfizer expects 24% vaccination rate in the United States for this fall with its COVID vaccines, chief financial officer David Denton said at a conference on Monday.
EU antitrust regulators set Oct. 19 deadline for Pfizer's Seagen deal
Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday.
Pfizer Inc. (PFE) Management presents at Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)
Pfizer Inc. (NYSE:PFE ) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 12:15 PM ET Company Participants Angela Hwang - CCO, President, Global Biopharmaceuticals Business...
3 Must-Know Tricks for Investing in Big Pharma Stocks
Pharma companies often have detailed plans for when new revenue will occur. They also sometimes describe periods when sales will be shrinking.
Pfizer Inc. (PFE) Citi's 18th Annual BioPharma Conference (Transcript)
Pfizer Inc. (NYSE:PFE ) Citi's 18th Annual BioPharma Conference September 7, 2023 10:30 AM ET Company Participants Mikael Dolsten - Chief Scientific Officer & President, Pfizer Research & Developme...
Pfizer says updated COVID shot generated strong reaction vs new variant in mice
Pfizer on Wednesday said the updated Pfizer-BioNTech COVID-19 vaccine expected to be used this fall elicited a strong antibody response against the highly mutated BA.2.86 subvariant of the coronavi...
Related Companies